Trade Candel Therapeutics Inc - CADL CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.06
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.02221 %(-$1.11)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: -0.02221%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.00002 %(-$0.00)Trade size with leverage ~ $5,000.00Money from leverage ~ $4,000.00Go to platform: -0.00002%
• Overnight funding adjustment time: 22:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.02221 %
  (-$1.11)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00002 %
  (-$0.00)

Key Stats

• Prev. Close: 9.32
• Open: 9.24
• 1-Year Change: 83.33%
• Day's Range: 9.19 - 9.49

Trade Candel Therapeutics Inc - CADL

What is Candel Therapeutics Inc (CADL)?

Candel Therapeutics Inc is a biotechnology company specializing in the development of oncolytic virus therapies for cancer treatment. The company focuses on engineering viruses that selectively infect and destroy cancer cells while stimulating the immune system to recognize and attack tumors. Its research and development efforts involve advanced genetic modification techniques to enhance the safety and efficacy of viral therapies. Candel Therapeutics operates within the biopharmaceutical sector, targeting unmet medical needs in oncology. The company collaborates with academic institutions and industry partners to advance its pipeline of therapeutic candidates. Its work contributes to the field of immuno-oncology, exploring innovative approaches to cancer treatment that combine direct tumor targeting with immune activation.

Candel Therapeutics Inc Stock Price Today: Live Overview

The price today is shaped by trading fluctuations, as Rithm Property Trust Inc trades at $9.3. The instrument's price moved between $9.2 and $9.49 during the session, with a daily change percentage of -0.2146%.

FAQ: Candel Therapeutics Inc (CADL)

What is the current price of CADL stock?

The current share price is $9.3.

Does CADL pay dividends?

Candel Therapeutics Inc does not pay dividends.

Does CADL have a formal corporate presence or regional headquarters in the UAE?

Candel Therapeutics Inc operates in the UAE only through partners and distributors without a registered presence.

What is CADL best known for?

The company is most famous for developing oncolytic virus immunotherapies.

What assets are typically shown together with CADL?

Commonly shown alongside CADL: American Capital, Dillards, Koppers Holdings Inc